Long-term consequences of childhood sexual abuse: An umbrella review of diagnostic meta-analyses.

EncephaleApr 9, 2026 (epub)
Clinical ResearchPsychiatry

Pol Thomas, Benjamin Fauquert, Nadine Kacenelenbogen et al.

✦ AI-curated · Sources linked

In 30 seconds

This umbrella review synthesised 38 meta-analyses of observational studies, covering about 20 million individuals, to map adult physical, psychiatric and behavioural outcomes associated with childhood sexual abuse (CSA). The review reported associations across all three domains. Among the highlighted estimates, sleep disorders had an odds ratio (OR) of 16.17 and borderline personality disorder an OR of 5.96; early sexual initiation had an OR of 3.59. The authors found no significant differences in consequences between men and women except for reproductive health outcomes. These findings describe associations and do not establish that CSA caused the outcomes.

Key findings

  • Sleep disorders were among the most prevalent mental health outcomes associated with CSA (OR=16.17).
  • Borderline personality disorder was associated with CSA (OR=5.96).
  • Early sexual initiation was a prominent behavioural outcome associated with CSA (OR=3.59).
  • The review found no significant sex differences in reported consequences except for reproductive health outcomes.

Why it matters

The review brings together evidence linking CSA with a broad range of adult health outcomes, underscoring its potential relevance when assessing patients with physical, psychiatric or behavioural concerns. The findings may support sensitive consideration of abuse history in clinical discussions, while recognising that the reported associations have multifactorial origins and do not establish causation.

What to keep in mind

The review notes that consequences have multifactorial origins and that definitions of abuse are problematic. Its findings synthesise observational meta-analyses, so they establish associations rather than causation.

Source

Published in Encephale. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.